TIRZEPATIDE AQ -30 MG / PEN -30 MG / 3 ML PEN
Description:
Dosage:
30 MG / PENQuantity:
30 MG / 3 ML PENWeight:
0.03680 KG
ZPHC PHARMA
Zhengzhou Pharmaceutical (ZPHC) is familiar for its stringent quality control standards as well as laboratory-tested preparations, guaranteeing safe and effective medicine and solutions.
Tags :
100% original guarantee
Return within 30days
Free Delivery on Domestic Orders above $500
🧬 Tirzepatide AQ – 30 mg / 3 ml Pen – ZPHC PHARMA
💉 Product Description
Tirzepatide is a novel dual-incretin peptide that acts as both:
- GLP-1 receptor agonist (Glucagon-Like Peptide-1)
- GIP receptor agonist (Glucose-Dependent Insulinotropic Polypeptide)
Manufactured by ZPHC PHARMA, this product comes as a ready-to-use aqueous solution in a prefilled pen (AQ), offering a simple and effective weekly dosing option.
📦 Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Tirzepatide AQ |
| Manufacturer | ZPHC PHARMA |
| Concentration | 30 mg / 3 ml (10 mg/ml) |
| Form | Prefilled Liquid Pen (AQ) |
| Route of Admin | Subcutaneous Injection |
| Dosing Frequency | Once Weekly |
⚙️ How It Works
Tirzepatide mimics natural incretin hormones, helping to regulate glucose and energy balance by:
- 🧬 Increasing insulin secretion when glucose is elevated
- 🧁 Suppressing glucagon (which raises blood sugar)
- 🍽️ Reducing appetite and promoting satiety
- 🔥 Enhancing fat oxidation and weight loss
🎯 Key Benefits (based on clinical research)
| Effect | Description |
|---|---|
| 🔻 Weight Loss | Reduces body weight up to 20–24% in 48 weeks |
| 🧪 Blood Sugar Control | Helps manage Type 2 Diabetes |
| 🧠 Appetite Reduction | Strong appetite suppression and cravings control |
| ❤️ Metabolic Health | Improves insulin sensitivity and lipid profile |
⏱️ Suggested Dosing Protocol
Start Low – Increase Gradually (to minimize side effects like nausea)
| Week | Suggested Weekly Dose |
|---|---|
| 1–2 | 2.5 mg |
| 3–4 | 5 mg |
| 5–6 | 7.5 mg |
| 7–8 | 10 mg |
| Beyond | Increase up to 15–20 mg based on tolerance and goals (max: 30 mg) |
- Injection site: abdomen or upper thigh (subcutaneous)
- Injection frequency: once weekly, same day each week
⚠️ Common Side Effects
| Side Effect | Frequency |
|---|---|
| Nausea | Common (early phase) |
| Vomiting | Possible with fast titration |
| Constipation | Mild to moderate |
| Fatigue / Dizziness | Occasionally |
| Low Appetite | Expected and desired for weight loss |
Symptoms usually subside after the first few doses.
🧊 Storage
- Refrigerate at 2–8°C (36–46°F)
- Do not freeze
- After opening, store in the fridge and use within the timeframe on label
🛡️ Cautions & Warnings
-
Not recommended for:
- People with history of medullary thyroid cancer
- Individuals with pancreatitis
- Consult a healthcare provider if using insulin or other antidiabetic drugs
✅ Summary
Tirzepatide AQ 30 mg / Pen by ZPHC is a potent dual-action peptide ideal for:
- 🔥 Advanced fat loss
- 🧬 Blood glucose control
- 🧠 Appetite suppression
- 🩺 Improving insulin resistance & metabolic health
Designed as a weekly injection, it's a powerful tool for those pursuing body transformation, especially when paired with proper nutrition and training.
| Brands | ZPHC PHARMA |